Latest Gland Pharma stock price

Gland Pharma P/E Ratio

GLAND • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
35.38
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 35.38
Current Price ₹1694.80
EPS (TTM) ₹42.40
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 42.26
Historical Range 30.45 - 64.12
Percentile 40.0%

Sector Context

Sector Average 57.57
Sector Median 36.22
Sector Rank #11 of 88
Sector Percentile 12.5%

Earnings Breakdown (TTM)

TTM EPS ₹45.48
Sept 2025 ₹11.15
Mar 2025 ₹11.32

Key P/E Ratio Insights for Gland Pharma

  • Stock appears overvalued with PE of 35.38, suggesting caution for new investments
  • Trading at discount to sector average PE of 57.57

View the GLAND equity price for detailed stock performance.

P/E Ratio Historical Trend for Gland Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 44.59 42.76 ₹1906.55 NSE High
2023 39.4 40.0 ₹1575.90 NSE High
2022 64.12 60.06 ₹3851.30 NSE High
2021 32.76 72.33 ₹2369.70 NSE High
2020 30.45 59.76 ₹1819.55 NSE High

Sector P/E Ratio Comparison

Comparing Gland Pharma with other companies in Healthcare sector
Sector Average
57.57
Sector Median
36.22
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate